Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...

Lupin transfers OTC business to subsidiary for Rs ₹550-650 crore, reports strong Q3 financial performance with profit and ...

Primarily lower sales as well as a steep fall in gross margins led to the weak financial performance of the company during ...

Deepak Nitrite for the December quarter is expected to post a steady performance with Q3 PAT declining 5.9 per cent on-year.

CorVel (NASDAQ:CRVL – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday. CorVel Price Performance ...

The Small Business Administration’s 7(a) loan program lost hundreds of millions of dollars in 2024, according to documents ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

NATCO Pharma stock has declined 34% over six days due to disappointing Q3 FY25 results, including a 37.4% revenue drop and a ...

Find all the Q3 results 2025 updates for Vodafone Idea, IRCTC, Khadim India, Bajaj Healthcare, Berger Paints, Zee Media, ...

Mullen Group Ltd. ("Mullen Group", "We", "Our" and/or the "Corporation"), one of Canada's largest logistics providers today reported its financial ...

Total expenses in the third quarter were lower at Rs 487.4 crore as compared to Rs 539.3 crore in the year-ago period, the ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...